IBOV 167,537.95 ▼ 1.34% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL5.85▼ 0.62% USD/MXN18.82▼ 0.18% USD/CLP1,007▲ 1.47% USD/COP3,342▲ 1.05% USD/PEN3.41▲ 0.05% USD/ARS1,559▼ 0.02% USD/UYU40.61▲ 3.30% USD/PYG6,212▲ 2.85% USD/BOB11.64▲ 3.02% USD/DOP60.01▼ 0.32% USD/CRC441.73▲ 2.49% USD/GTQ7.64▲ 3.23% USD/HNL26.89▼ 0.14% USD/NIO36.62▲ 0.26% USD/VES913.46▼ 0.35% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.28% USD/TTD6.70▲ 2.24% EUR/BRL6.44▲ 1.44% BRENT 89.61 ▼ 2.54% WTI 82.60 ▼ 0.79% IRON ORE 161.91 — — COPPER 5.65 ▼ 0.11% GOLD 3,729 ▼ 0.36% SILVER 44.97 ▼ 0.06% SOY 1,219 ▲ 0.18% CORN 447.50 ▲ 2.76% WHEAT 585.75 ▲ 2.76% COFFEE 281.30 ▼ 1.85% SUGAR 18.07 ▲ 0.17% ORANGE JUICE 129.10 ▼ 4.37% COTTON 79.60 ▲ 6.18% COCOA 4,870 ▼ 3.18% BEEF 219.90 ▲ 0.51% CATTLE 336.85 ▲ 0.38% LITHIUM 55.57 ▼ 1.51% PETR4 43.17 ▼ 1.84% VALE3 59.00 ▼ 2.22% ITUB4 40.19 ▼ 1.71% BBDC4 14.08 ▼ 2.29% ABEV3 16.07 ▲ 0.88% BBAS3 14.12 ▼ 3.42% B3SA3 14.30 ▼ 2.39% WEGE3 51.38 ▲ 0.45% PRIO3 61.87 ▼ 3.27% SUZB3 55.60 ▲ 0.38% RENT3 29.45 ▼ 0.71% AZZA3 15.78 ▲ 0.90% CSAN3 3.13 ▼ 3.69% RAIZ4 16.80 ▼ 9.14% PCAR3 2.99 ▲ 3.46% GMAT3 4.05 ▼ 3.11% PSSA3 44.66 ▼ 2.74% CVCB3 0.78 — 0.00% POSI3 3.17 ▲ 1.28% SLCE3 17.88 ▼ 1.00% NATU3 4.78 ▲ 0.63% BRKM5 2.63 ▼ 4.36% RANI3 8.07 ▼ 1.82% IBOV 167,537.95 ▼ 1.34% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL 5.85 ▼ 0.62% USD/MXN 18.86 ▲ 0.02% USD/CLP 1,007 ▲ 1.47% USD/COP 3,342 ▲ 1.05% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,559 ▼ 0.02% USD/UYU 40.61 ▲ 3.19% USD/PYG 6,212 ▲ 2.85% USD/BOB 11.64 ▲ 3.02% USD/DOP 60.01 ▼ 0.32% USD/CRC 441.73 ▲ 2.49% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▼ 0.14% USD/NIO 36.62 ▲ 0.26% USD/VES 913.46 ▼ 0.35% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.28% USD/TTD 6.70 ▲ 2.24% EUR/BRL 6.42 ▲ 1.12% BRENT 89.61 ▼ 2.54% WTI 82.60 ▼ 0.79% IRON ORE 161.91 — — COPPER 5.65 ▼ 0.11% GOLD 3,729 ▼ 0.36% SILVER 44.97 ▼ 0.06% SOY 1,219 ▲ 0.18% CORN 447.50 ▲ 2.76% WHEAT 585.75 ▲ 2.76% COFFEE 281.30 ▼ 1.85% SUGAR 18.07 ▲ 0.17% ORANGE JUICE 129.10 ▼ 4.37% COTTON 79.60 ▲ 6.18% COCOA 4,870 ▼ 3.18% BEEF 219.90 ▲ 0.51% CATTLE 336.85 ▲ 0.38% LITHIUM 55.57 ▼ 1.51% PETR4 43.17 ▼ 1.84% VALE3 59.00 ▼ 2.22% ITUB4 40.19 ▼ 1.71% BBDC4 14.08 ▼ 2.29% ABEV3 16.07 ▲ 0.88% BBAS3 14.12 ▼ 3.42% B3SA3 14.30 ▼ 2.39% WEGE3 51.38 ▲ 0.45% PRIO3 61.87 ▼ 3.27% SUZB3 55.60 ▲ 0.38% RENT3 29.45 ▼ 0.71% AZZA3 15.78 ▲ 0.90% CSAN3 3.13 ▼ 3.69% RAIZ4 16.80 ▼ 9.14% PCAR3 2.99 ▲ 3.46% GMAT3 4.05 ▼ 3.11% PSSA3 44.66 ▼ 2.74% CVCB3 0.78 — 0.00% POSI3 3.17 ▲ 1.28% SLCE3 17.88 ▼ 1.00% NATU3 4.78 ▲ 0.63% BRKM5 2.63 ▼ 4.36% RANI3 8.07 ▼ 1.82%
since 2009
Thursday, November 19, 2026

Brazil Business - Brazil

Brazil’s Largest Hospital Chain Moves to Absorb Leading Lab Group in Market Shake-Up

By · · 2 min read
Brazil’s Largest Hospital Chain Moves to Absorb Leading Lab Group in Market Shake-Up
Brazil’s Largest Hospital Chain Moves to Absorb Leading Lab Group in Market Shake-Up.

Rede D’Or, Brazil’s largest private hospital operator, is taking steps to buy Grupo Fleury, the country’s leading medical testing and diagnostic network.

The talks, confirmed by both companies in July 2025, show how two of Brazil’s strongest health businesses want to join forces as competition and costs rise.

Rede D’Or runs 79 hospitals and manages over 13,000 beds, with sites across Brazil’s biggest cities. In 2024, Rede D’Or earned R$51.3 billion in revenue and R$3.93 billion in profit. Its hospitals ran at a healthy 77% capacity.

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

The company keeps adding new beds, with plans to grow capacity by almost half over the next three years. Rede D’Or’s finances remain stable despite carrying R$17.8 billion in debt, with a manageable debt-to-earnings ratio.

Fleury, with over 22,000 employees and 5,000 doctors, focuses on lab tests, imaging, and specialty medical exams. It earned R$8.3 billion in revenue and R$616 million in profit last year.

RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Fleury keeps buying smaller labs but says it only expands when prices and culture fit its standards. This possible deal comes as Brazil’s private health market faces major changes.

No single group dominates, because rules and high costs keep the sector chopped up. Brazil’s aging population and new, expensive treatments push up bills for patients and insurers.

Big companies like Rede D’Or and Fleury see merging as the best way to save money, offer more to patients, and stand stronger against rising costs. The game has been building for years.

Fifteen years ago, Rede D’Or’s owners sold their lab chain to Fleury for about R$1.2 billion. Now, both sides see a chance to put hospital and testing services together under one roof.

If Rede D’Or succeeds, the joined company would handle everything from hospital stays to blood tests for millions of Brazilians. That could mean faster, better service for patients—if the two firms manage the change well.

For smaller rivals, though, it makes survival even harder in a market where size and reach matter more every year. This deal marks a big moment for Brazil’s health system, highlighting how the race for scale and efficiency is changing care as much as policy or medicine does.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.